Stephanie Culler

Co-Founder and CEO of Persephone Biosciences

[Stephanie Culler @StephJCuller]

How the Microbiome Could Be the Key to New Cancer Treatments https://t.co/5n6YYNqpBq via @SmithsonianMag

[Persephone Biosciences @PersephoneBio]

Why is #colorectalcancer research so important? Early-onset #CRC is on the rise, while survival rates remain low. But early detection can > survival by 77%. Schedule a #colonoscopy & sign up for the #ARGONAUT study to protect your health & help science. https://t.co/UETw12NPlt

[Persephone Biosciences @PersephoneBio]

Contribute to public health while protecting yours! You can help us better understand and treat #colorectalcancer by participating in the #ARGONAUT study during your routine #colonoscopy.

Learn more: https://t.co/UETw12NPlt

#crcsm #GetScreened @JanssenUS

[Persephone Biosciences @PersephoneBio]

Could the composition of the #microbiome in early life be contributing to an emerging rise in early-onset #cancer? Researchers from @harvardmed and @BrighamWomens examine the potential reasons behind a dramatic rise in cancer in people under 50. https://t.co/XqdhQiCqdH

[NYSE 🏛 @NYSE]

The #microbiome is associated with virtually every disease we know and it lives in the gut. @PersephoneBio CEO @StephJCuller tells us how studying stool samples💩 can help scientists develop ways to fight disease. #NYSEFloorTalk

[Stephanie Culler @StephJCuller]

Participate in @PersephoneBio's clinical research study focused on infant gut health by donating a sample of your baby’s poop to help us develop treatments to support a healthy gut microbiome. Register at https://t.co/Zuq82U4jit https://t.co/mLxbmodbDG

[Persephone Biosciences @PersephoneBio]

Where is Persephone going next? @StephJCuller gives @sdut readers a sneak peek into our next indication, alongside oncology.

[Persephone Biosciences @PersephoneBio]

🎉 Happy birthday to us! And we're celebrating the 5yr anniversary of our founding with a great gift from forward-thinking investors who are committed to the vast potential of our #AI platform & #synbio tech: $15 million in financing. 🎉

Read more: https://t.co/jq201V2b80

[Persephone Biosciences @PersephoneBio]

Could the efficacy of #COVID19 vaccines and therapy be improved by strengthening the #microbiome of patients whose gut health is out of balance? There's a lot of evidence that says yes, and here's how it could be done:

https://t.co/AwZ2hTHZ84

[Stephanie Culler @StephJCuller]

To fight coronavirus, researchers are seeking poop samples https://t.co/mGwFbrg5eR #FoxNews

[Stephanie Culler @StephJCuller]

@SanDiegOmics @JonathanWosen @sdut @sdbn @big4bioSD @mcdiana @biocom @CALifeSciences @JLABS @grobbins The study will begin with an initial pilot study of a few hundred adults, and scale to over 10,000 participants nationwide using a decentralized clinical trial approach.

[Jonathan Wosen, Ph.D. @JonathanWosen]

If you're planning on getting a #COVID19 vaccine, this San Diego biotech wants your poop. My latest for @sdut on what Persephone Biosciences is up to (and why). @sdbn @big4bioSD @mcdiana @biocom @CALifeSciences @JLABS @grobbins
https://t.co/UyT3WgH3Rm

[Voices Study @VoicesStudy]

Hey Twitter! We’re the VOICES Study team, and we’re so excited to share our program with you. VOICES is a compensated clinical study aimed at involving historically-excluded minority groups in the creation of novel medicines. Enroll now! #JoinVOICES #HealthEquity #microbiome

[Persephone Biosciences @PersephoneBio]

We are excited to be featured in the most recent edition of GEN. Read full article: https://t.co/rAycuUzqOm

[Persephone Biosciences @PersephoneBio]

We recently initiated the ARGONAUT Study, the largest ever clinical study to map the cancer gut microbiome immune axis in the U.S. @PersephoneBio is actively seeking investigators in oncology to collaborate in this ground-breaking study. For more info: https://t.co/241vacpHLf

[Stephanie Culler @StephJCuller]

The world needs more women-led companies. On November 18th, join YC for their first Future Founder Conference, a virtual event for women globally and learn how to start a startup from inspiring entrepreneurs: https://t.co/6WslFNEtrQ

[Johnson & Johnson Innovation @JNJInnovation]

#BLUEKNIGHT aims to stimulate the innovation & incubation of potential solutions to protect our communities. Learn more about this collaboration between @JLABS & @BARDA: https://t.co/e8mMWpLyLP

[Johnson & Johnson Innovation @JNJInnovation]

#JNJInnovation & @BARDA select first cohort of
@JLABS companies with the aim to combat #COVID19 as part of the #BLUEKNIGHT collaboration: https://t.co/g6KSX5t3xh

[Curebase @CurebaseDCT]

Curebase in the news! Excited to have @GeneOnlineNews cover our story on CURE-19 and at-home COVID-19 clinical research. #clinicaltrials #covid19research

https://t.co/TTR4AjNQHR

[Curebase @CurebaseDCT]

Curebase is announcing the launch of CURE-19, a platform for at-home COVID-19 clinical trials. We've been live since Friday and already have hundreds of patients on the platform. #researchathome #covid19 #clinicaltrials

https://t.co/jv1bV3d3rr

[Stephanie Culler @StephJCuller]

Microbiome Targeted Therapeutics May Have Role in COVID-19 Fight https://t.co/ec177Z7Eof